STAAR SURGICAL CO

STAA

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Deerfield Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Deerfield ManagementNEWFeb 17, 2026

Shares: 51,894Value: $1.2M

# Signal Note: Deerfield Healthcare Initiates STAA Position Deerfield's $1.2M entry into STAAR Surgical suggests conviction in the refractive surgery device market, likely driven by expanding SMILE (small incision lenticule extraction) adoption and competitive positioning against LASIK alternatives. The timing aligns with STAA's international growth trajectory and potential for market share gains in the $5B+ global corneal surgery market. Flynn's healthcare multi-strategy mandate indicates fundamental reassessment of STAA's valuation or near-term catalysts (procedure volume recovery, margin expansion post-pandemic).

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

RDNT1 fund VTR1 fund PHVS1 fund PMVP1 fund ALHC1 fund ATRC1 fund BCRX1 fund NBIX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: